JP2014501758A5 - - Google Patents

Download PDF

Info

Publication number
JP2014501758A5
JP2014501758A5 JP2013546071A JP2013546071A JP2014501758A5 JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5 JP 2013546071 A JP2013546071 A JP 2013546071A JP 2013546071 A JP2013546071 A JP 2013546071A JP 2014501758 A5 JP2014501758 A5 JP 2014501758A5
Authority
JP
Japan
Prior art keywords
protein
ligand
domain
domains
asparagine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014501758A (ja
JP5974342B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2011/051536 external-priority patent/WO2012087230A1/en
Publication of JP2014501758A publication Critical patent/JP2014501758A/ja
Publication of JP2014501758A5 publication Critical patent/JP2014501758A5/ja
Application granted granted Critical
Publication of JP5974342B2 publication Critical patent/JP5974342B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546071A 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス Active JP5974342B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424725P 2010-12-20 2010-12-20
US61/424,725 2010-12-20
PCT/SE2011/051536 WO2012087230A1 (en) 2010-12-20 2011-12-19 Affinity chromatography matrix

Publications (3)

Publication Number Publication Date
JP2014501758A JP2014501758A (ja) 2014-01-23
JP2014501758A5 true JP2014501758A5 (enExample) 2015-02-05
JP5974342B2 JP5974342B2 (ja) 2016-08-23

Family

ID=46314245

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546071A Active JP5974342B2 (ja) 2010-12-20 2011-12-19 アフィニティークロマトグラフィーマトリックス

Country Status (5)

Country Link
US (1) US9683013B2 (enExample)
EP (1) EP2654915B1 (enExample)
JP (1) JP5974342B2 (enExample)
CN (1) CN103269761B (enExample)
WO (1) WO2012087230A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
CN103748221A (zh) * 2011-08-04 2014-04-23 独立行政法人产业技术综合研究所 由蛋白g细胞膜外结构域突变体的串联型多聚体组成的新型改性蛋白
WO2013081540A1 (en) * 2011-11-30 2013-06-06 Ge Healthcare Bio-Sciences Ab Affinity chromatography matrix
JP6420756B2 (ja) * 2012-03-28 2018-11-07 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ アフィニティークロマトグラフィーマトリックス
IN2015DN02055A (enExample) 2012-09-17 2015-08-14 Grace W R & Co
US11229896B2 (en) 2014-01-16 2022-01-25 W.R. Grace & Co.—Conn. Affinity chromatography media and chromatography devices
CN104945488B (zh) * 2014-03-27 2020-02-18 迈格生物医药(上海)有限公司 一种具有免疫球蛋白结合能力的多肽
ES2929099T3 (es) 2014-05-02 2022-11-24 Grace W R & Co Material de soporte funcionalizado y métodos de fabricación y uso de material de soporte funcionalizado
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN107108700B (zh) * 2014-12-17 2023-02-17 思拓凡生物工艺研发有限公司 修饰的κ轻链-结合多肽
ES2896897T3 (es) 2015-06-05 2022-02-28 Grace W R & Co Agentes de clarificación para el bioprocesamiento de adsorbentes y métodos para producir y usar los mismos
GB201515339D0 (en) * 2015-08-28 2015-10-14 Ge Healthcare Bio Sciences Ab A seperation matrix and a method of seperating antibodies
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10513537B2 (en) 2016-05-11 2019-12-24 Ge Healthcare Bioprocess R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
CN109311949B (zh) 2016-05-11 2022-09-16 思拓凡生物工艺研发有限公司 储存分离基质的方法
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
WO2017194593A1 (en) 2016-05-11 2017-11-16 Ge Healthcare Bioprocess R&D Ab Method of cleaning and/or sanitizing a separation matrix
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
KR101857953B1 (ko) * 2016-07-06 2018-05-16 아미코젠주식회사 알칼리 내성이 증가된 변이 면역글로불린 결합 단백질
GB201615254D0 (en) 2016-09-08 2016-11-23 Ge Healthcare Bio Sciences Ab Novel Ligand and use thereof
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
CN110799521A (zh) 2017-02-15 2020-02-14 拜奥普罗塞亚科技有限责任公司 具有温和洗脱pH的亲和色谱配体
GB201708277D0 (en) 2017-05-24 2017-07-05 Ge Healthcare A Recombinant protein
EP3875472A1 (en) 2020-03-06 2021-09-08 Navigo Proteins Gmbh Novel immunoglobulin binding polypeptides
EP4229068A1 (en) 2020-10-13 2023-08-23 Avitide LLC Affinity ligand libraries of three-helix bundle proteins and uses thereof
GB202018588D0 (en) 2020-11-26 2021-01-13 Cytiva Bioprocess R & D Ab Separation matrix
US20240236347A9 (en) 2021-02-19 2024-07-11 Avitide LLC Aav2 affinity agents
GB202113626D0 (en) 2021-09-24 2021-11-10 Cytiva Bioprocess R & D Ab FC binding polypeptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8505922D0 (sv) 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US6602977B1 (en) * 1999-04-19 2003-08-05 Biovitrum Ab Receptor structures
US7709209B2 (en) 2002-03-25 2010-05-04 Ge Healthcare Bio-Sciences Ab Protein ligands
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
ATE416190T1 (de) * 2003-07-04 2008-12-15 Affibody Ab Polypeptide mit bindungsaffinität für her2
SE0400274D0 (sv) 2004-02-09 2004-02-09 Affibody Ab New polypeptide
US7993848B2 (en) * 2005-03-01 2011-08-09 Affibody Ab Staphylococcus protein A domain mutants that bind to TNF-α
CN102989018A (zh) * 2005-08-03 2013-03-27 Rq生物科技有限公司 用于诊断IgA和IgM介导的肾脏疾病的方法和组合物
JP5229888B2 (ja) 2008-09-30 2013-07-03 独立行政法人産業技術総合研究所 弱酸性域での易解離性を向上したプロテインa変異型タンパク質及び抗体捕捉剤
CN102272145B (zh) * 2009-01-12 2014-07-30 通用电气健康护理生物科学股份公司 亲和色谱基质

Similar Documents

Publication Publication Date Title
JP2014501758A5 (enExample)
JP2014500311A5 (enExample)
JP2012515160A5 (enExample)
JP2014502272A5 (enExample)
Gaberc‐Porekar et al. Potential for using histidine tags in purification of proteins at large scale
Zhao et al. Biomimetic design of affinity peptide ligands for human IgG based on protein A-IgG complex
JP2007252368A5 (enExample)
JP2019531055A5 (enExample)
Zachariou et al. Application of immobilized metal ion chelate complexes as pseudocation exchange adsorbents for protein separation
US20100069617A1 (en) Enhanced protein aggregate removal by mixed mode chromatography on hydrophobic interaction media in the presence of protein-excluded zwitterions
CN107001432A (zh) 突变的免疫球蛋白结合多肽
JP2019034963A (ja) 陽イオン交換基を用いた新規抗体精製法(Novel Antibody Purification method using Cation Exchanger)
JP2016525100A5 (enExample)
JP2007532477A5 (enExample)
JP2018523994A (ja) 新規な免疫グロブリン結合タンパク質およびアフィニティ精製におけるそれらの使用
EP4371996A3 (en) Methods for purifying antibodies
CN105377881A (zh) 突变的免疫球蛋白结合多肽
WO2011118599A1 (ja) アフィニティークロマトグラフィー用充填剤およびイムノグロブリンを単離する方法
Nian et al. Void exclusion of antibodies by grafted-ligand porous particle anion exchangers
RU2014118552A (ru) Способ выделения фукозилированных антител
CN104603153B (zh) 用于抗体纯化的载体、其制备方法及其应用
JP2015518489A5 (enExample)
JP2011001336A (ja) 新規なプロテインa固定化担体の製造方法
Opitz et al. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography
Gomes et al. Magnetic hydrophobic‐charge induction adsorbents for the recovery of immunoglobulins from antiserum feedstocks by high‐gradient magnetic fishing